Harnessing nanomedicine for mucosal theranostics -A silver bullet at last?

ACS Nano

Volumn 7, Issue 4, 2013, Pages 2883-2890

  Elinav, Eran ^a   Peer, Dan ^b,c  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b Department of Cell Research and Immunology ^*  (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECT; ANIMAL MODEL; DISEASE MANAGEMENT; IMAGING MODALITY; INFLAMMATORY BOWEL DISEASE; THERANOSTICS; THERAPEUTIC TARGETS;

MOLECULAR IMAGING;

MEDICAL NANOTECHNOLOGY;

NANOPARTICLE; DIAGNOSTIC AGENT;

DIAGNOSTIC USE; DRUG EFFECTS; HUMAN; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; MOLECULAR IMAGING; NANOMEDICINE; PATHOLOGY; PROCEDURES; TRENDS; ARTICLE; DRUG EFFECT; INFLAMMATORY BOWEL DISEASE; METHODOLOGY;

HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MOLECULAR IMAGING; NANOMEDICINE; NANOPARTICLES;

EID: 84876582076     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn400885b     Document Type: Review

References (55)

1. Ordas, I.; Eckmann, L.; Talamini, M.; Baumgart, D. C.; Sandborn, W. J. Ulcerative Colitis Lancet 2012, 380, 1606-1619
2. Baumgart, D. C.; Sandborn, W. J. Crohn's Disease Lancet 2012, 380, 1590-1605
3. Peyrin-Biroulet, L.; Loftus, E. V., Jr.; Colombel, J. F.; Sandborn, W. J. Long-Term Complications, Extraintestinal Manifestations, and Mortality in Adult Crohn's Disease in Population-Based Cohorts Inflammatory Bowel Dis. 2011, 17, 471-478
4. Sinclair, J. A.; Wasan, S. K.; Farraye, F. A. Health Maintenance in the Inflammatory Bowel Disease Patient Clin. Gastroenterol. 2012, 41, 325-337
5. Burger, D.; Travis, S. Conventional Medical Management of Inflammatory Bowel Disease Gastroenterology 2011, 140, 1827-1837
6. Pellish, R. S.; Nasir, A.; Ramratnam, B.; Moss, S. F. Review Article: RNA Interference-Potential Therapeutic Applications for the Gastroenterologist Aliment. Pharmacol. Ther. 2008, 27, 715-723
7. Siegmund, B.; Zeitz, M. Innate and Adaptive Immunity in Inflammatory Bowel Disease World J. Gastroenterol. 2011, 17, 3178-3183
8. Zigmond, E.; Varol, C.; Farache, J.; Elmaliah, E.; Satpathy, A. T.; Friedlander, G.; Mack, M.; Shpigel, N.; Boneca, I. G.; Murphy, K. M. et al. Ly6C(hi) Monocytes in the Inflamed Colon Give Rise to Proinflammatory Effector Cells and Migratory Antigen-Presenting Cells Immunity 2012, 37, 1076-1090
9. Varol, C.; Vallon-Eberhard, A.; Elinav, E.; Aychek, T.; Shapira, Y.; Luche, H.; Fehling, H. J.; Hardt, W. D.; Shakhar, G.; Jung, S. Intestinal Lamina Propria Dendritic Cell Subsets Have Different Origin and Functions Immunity 2009, 31, 502-512
10. Duerr, R. H.; Taylor, K. D.; Brant, S. R.; Rioux, J. D.; Silverberg, M. S.; Daly, M. J.; Steinhart, A. H.; Abraham, C.; Regueiro, M.; Griffiths, A. et al. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene Science 2006, 314, 1461-1463
11. O'Shea, J. J.; Ma, A.; Lipsky, P. Cytokines and Autoimmunity Nat. Rev. Immunol. 2002, 2, 37-45
12. Arthur, J. C.; Perez-Chanona, E.; Mühlbauer, M.; Tomkovich, S.; Uronis, J. M.; Fan, T.-J.; Campbell, B. J.; Abujamel, T.; Dogan, B.; Rogers, A. B. et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota Science 2012, 338, 120-123
13. Pils, M. C.; Bleich, A.; Prinz, I.; Fasnacht, N.; Bollati-Fogolin, M.; Schippers, A.; Rozell, B.; Müller, W. Commensal Gut Flora Reduces Susceptibility to Experimentally Induced Colitis via T-Cell-Derived Interleukin-10 Inflammatory Bowel Dis. 2011, 17, 2038-2046
14. Kotlarz, D.; Beier, R.; Murugan, D.; Diestelhorst, J.; Jensen, O.; Boztug, K.; Pfeifer, D.; Kreipe, H.; Pfister, E. D.; Baumann, U. et al. Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy Gastroenterology 2012, 143, 347-355
15. Elinav, E.; Henao-Mejia, J.; Flavell, R. A. Integrative Inflammasome Activity in the Regulation of Intestinal Mucosal Immune Responses Mucosal Immunol. 2013, 6, 4-13
16. Strowig, T.; Henao-Mejia, J.; Elinav, E.; Flavell, R. Inflammasomes in h=Health and Disease Nature 2012, 481, 278-286
17. Elinav, E.; Strowig, T.; Kau, A. L.; Henao-Mejia, J.; Thaiss, C. A.; Booth, C. J.; Peaper, D. R.; Bertin, J.; Eisenbarth, S. C.; Gordon, J. I. et al. NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis Cell 2011, 145, 745-757
18. Goto, Y.; Kiyono, H. Epithelial Barrier: An Interface for the Cross-Communication between Gut Flora and Immune System Immunol. Rev. 2012, 245, 147-163
19. Ogura, Y.; Bonen, D. K.; Inohara, N.; Nicolae, D. L.; Chen, F. F.; Ramos, R.; Britton, H.; Moran, T.; Karaliuskas, R.; Duerr, R. H. et al. A Frameshift Mutation in NOD2 Associated with Susceptibility to Crohn's Disease Nature 2001, 411, 603-606
20. Kabashima, K.; Saji, T.; Murata, T.; Nagamachi, M.; Matsuoka, T.; Segi, E.; Tsuboi, K.; Sugimoto, Y.; Kobayashi, T.; Miyachi, Y. et al. The Prostaglandin Receptor EP4 Suppresses Colitis, Mucosal Damage and CD4 Cell Activation in the Gut J. Clin. Invest. 2002, 109, 883-893
21. Sela-Passwell, N.; Kikkeri, R.; Dym, O.; Rozenberg, H.; Margalit, R.; Arad-Yellin, R.; Eisenstein, M.; Brenner, O.; Shoham, T.; Danon, T. et al. Antibodies Targeting the Catalytic Zinc Complex of Activated Matrix Metalloproteinases Show Therapeutic Potential Nat. Med. 2012, 18, 143-147
22. Sartor, R. B. Genetics and Environmental Interactions Shape the Intestinal Microbiome To Promote Inflammatory Bowel Disease versus Mucosal Homeostasis Gastroenterology 2010, 139, 1816-1819
23. Preidis, G. A.; Versalovic, J. Targeting the Human Microbiome with Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era Gastroenterology 2009, 136, 2015-2031
24. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
25. Moghimi, S. M.; Peer, D.; Langer, R. Reshaping the Future of Nanopharmaceuticals Ad Iudicium ACS Nano. 2011, 5, 8454-8458
26. Capurso, N. A.; Fahmy, T. M. Development of a pH-Responsive Particulate Drug Delivery Vehicle for Localized Biologic Therapy in Inflammatory Bowel Disease Yale J. Biol. Med. 2011, 84, 285-288
27. Coco, R.; Plapied, L.; Pourcelle, V.; Jéroîme, C.; Brayden, D. J.; Schneider, Y. J.; Préat, V. Drug Delivery to Inflamed Colon by Nanoparticles: Comparison of Different Strategies Int. J. Pharm. 2013, 440, 3-12
28. Collnot, E. M.; Ali, H.; Lehr, C. M. Nano-and Microparticulate Drug Carriers for Targeting of the Inflamed Intestinal Mucosa J. Controlled Release 2012, 161, 235-246
29. Kshirsagar, S. J.; Bhalekar, M. R.; Patel, J. N.; Mohapatra, S. K.; Shewale, N. S. Preparation and Characterization of Nanocapsules for Colon-Targeted Drug Delivery System Pharm. Dev. Technol. 2012, 17, 607-613
30. Lamprecht, A. IBD: Selective Nanoparticle Adhesion Can Enhance Colitis Therapy Nat. Rev. Gastroenterol. Hepatol. 2010, 7, 311-312
31. Laroui, H.; Dalmasso, G.; Nguyen, H. T.; Yan, Y.; Sitaraman, S. V.; Merlin, D. Drug-Loaded Nanoparticles Targeted to the Colon with Polysaccharide Hydrogel Reduce Colitis in a Mouse Model Gastroenterology 2010, 138, 843-853
32. Schmidt, C.; Lautenschlaeger, C.; Collnot, E. M.; Schumann, M.; Bojarski, C.; Schulzke, J. D.; Lehr, C. M.; Stallmach, A. Nano-and Microscaled Particles for Drug Targeting to Inflamed Intestinal Mucosa: A First In Vivo Study in Human Patients J. Controlled Release 2013, 165, 139-145
33. Peer, D.; Park, E. J.; Morishita, Y.; Carman, C. V.; Shimaoka, M. Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target Science 2008, 319, 627-630
34. Mora, J. R.; Bono, M. R.; Manjunath, N.; Weninger, W.; Cavanagh, L. L.; Rosemblatt, M.; Von Andrian, U. H. Selective Imprinting of Gut-Homing T Cells by Peyer's Patch Dendritic Cells Nature 2003, 424, 88-93
35. 7 Suppresses Lymphocyte Migration to the Gut J. Clin. Invest. 2007, 117, 2526-2538
36. Shaw, S. K.; Brenner, M. B. The Beta 7 Integrins in Mucosal Homing and Retention Semin. Immunol. 1995, 7, 335-342
37. Ben-Arie, N.; Kedmi, R.; Peer, D. Integrin-Targeted Nanoparticles for siRNA Delivery Methods Mol. Biol. 2012, 757, 497-507
38. Maclachlan, I. siRNAs with Guts Nat. Biotechnol. 2008, 26, 403-405
39. Peer, D.; Park, E. J.; Morishita, Y.; Carman, C. V.; Shimaoka, M. Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-inflammatory Target Science 2008, 319, 627-630
40. Daka, A.; Peer, D. RNAi-Based Nanomedicines for Targeted Personalized Therapy Adv. Drug Delivery Rev. 2012, 64, 1508-1521
41. Laroui, H.; Sitaraman, S. V.; Merlin, D. Gastrointestinal Delivery of Anti-Inflammatory Nanoparticles Methods Enzymol. 2012, 509, 101-125
42. Laroui, H.; Wilson, D. S.; Dalmasso, G.; Salaita, K.; Murthy, N.; Sitataman, S. V.; Merlin, D. Nanomedicine in GI Am. J. Physiol. 2011, 300, G371-G383
43. Wilson, D. S.; Dalmasso, G.; Wang, L.; Sitaraman, S. V.; Merlin, D.; Murthy, N. Orally Delivered Thioketal Nanoparticles Loaded with TNF-α-siRNA Target Inflammation and Inhibit Gene Expression in the Intestines Nat. Mater. 2010, 9, 923-928
44. Bouziotis, P.; Psimadas, D.; Tsotakos, T.; Stamopoulos, D.; Tsoukalas, C. Radiolabeled Iron Oxide Nanoparticles as Dual-Modality SPECT/MRI and PET/MRI Agents Curr. Top. Med. Chem. 2012, 12, 2694-2702
45. Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; Rivera, B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L. Nanoshell-Mediated Near-Infrared Thermal Therapy of Tumors under Magnetic Resonance Guidance Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13549-13554
46. Marchesano, V.; Hernandez, Y.; Salvenmoser, W.; Ambrosone, A.; Tino, A.; Hobmayer, B.; de la Fuente, J. M.; Tortiglione, C. Imaging Inwards and Outwards Trafficking of Gold Nanoparticles in Whole Animals ACS Nano 2013, 7, 2431-2442
47. Yin, Z. F.; Wu, L.; Yang, H. G.; Su, Y. H. Recent Progress in Biomedical Applications of Titanium Dioxide Phys. Chem. Chem. Phys. 2013, 15, 4844-4858
48. Berkova, Z.; Jirak, D.; Zacharovova, K.; Lukes, I.; Kotkova, Z.; Kotek, J.; Kacenka, M.; Kaman, O.; Rehor, I.; Hajek, M. et al. Gadolinium-and Manganite-Based Contrast Agents with Fluorescent Probes for Both Magnetic Resonance and Fluorescence Imaging of Pancreatic Islets: A Comparative Study ChemMedChem. 2013, 8, 614-621
49. Godin, B.; Tasciotti, E.; Liu, X.; Serda, R. E.; Ferrari, M. Multistage Nanovectors: From Concept to Novel Imaging Contrast Agents and Therapeutics Acc. Chem. Res. 2011, 44, 979-989
50. 7 Integrin Antibody Inflammatory Bowel Dis. 2010, 16, 1458-1466
51. 7 Integrin Antibody Methods Mol. Biol. 2012, 757, 487-496
52. Kirui, D. K.; Khalidov, I.; Wang, Y.; Batt, C. A. Targeted Near-IR Hybrid Magnetic Nanoparticles for In Vivo Cancer Therapy and Imaging Nanomedicine 2012, 10.1016/j.nano.2012.11.009
53. 1 Contrast Nat. Nanotechnol. 2010, 5, 815-821
54. Karton-Lifshin, N.; Segal, E.; Omer, L.; Portnoy, M.; Satchi-Fainaro, R.; Shabat, D. A Unique Paradigm for a Turn-On Near-Infrared Cyanine-Based Probe: Noninvasive Intravital Optical Imaging of Hydrogen Peroxide J. Am. Chem. Soc. 2011, 133, 10960-10965
55. Schroeder, A.; Heller, D. A.; Winslow, M. M.; Dahlman, J. E.; Pratt, G. W.; Langer, R.; Jacks, T.; Anderson, D. G. Treating Metastatic Cancer with Nanotechnology Nat. Rev. Cancer. 2012, 12, 39-50